162 related articles for article (PubMed ID: 36555229)
21. Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
Wang L; Kazmierczak K; Yuan CC; Yadav S; Kawai M; Szczesna-Cordary D
FEBS J; 2017 Jun; 284(12):1897-1913. PubMed ID: 28467684
[TBL] [Abstract][Full Text] [Related]
22. The effect of myosin regulatory light chain phosphorylation on the frequency-dependent regulation of cardiac function.
Dias FA; Walker LA; Arteaga GM; Walker JS; Vijayan K; Peña JR; Ke Y; Fogaca RT; Sanbe A; Robbins J; Wolska BM
J Mol Cell Cardiol; 2006 Aug; 41(2):330-9. PubMed ID: 16806259
[TBL] [Abstract][Full Text] [Related]
23. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
[TBL] [Abstract][Full Text] [Related]
24. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
[TBL] [Abstract][Full Text] [Related]
25. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
[TBL] [Abstract][Full Text] [Related]
26. The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts.
Muthu P; Kazmierczak K; Jones M; Szczesna-Cordary D
J Cell Mol Med; 2012 Apr; 16(4):911-9. PubMed ID: 21696541
[TBL] [Abstract][Full Text] [Related]
27. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
[TBL] [Abstract][Full Text] [Related]
28. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.
Ahmad F; Banerjee SK; Lage ML; Huang XN; Smith SH; Saba S; Rager J; Conner DA; Janczewski AM; Tobita K; Tinney JP; Moskowitz IP; Perez-Atayde AR; Keller BB; Mathier MA; Shroff SG; Seidman CE; Seidman JG
PLoS One; 2008 Jul; 3(7):e2642. PubMed ID: 18612386
[TBL] [Abstract][Full Text] [Related]
29. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice.
Kazmierczak K; Muthu P; Huang W; Jones M; Wang Y; Szczesna-Cordary D
Biochem J; 2012 Feb; 442(1):95-103. PubMed ID: 22091967
[TBL] [Abstract][Full Text] [Related]
30. Impact of cardiac myosin light chain kinase gene mutation on development of dilated cardiomyopathy.
Hodatsu A; Fujino N; Uyama Y; Tsukamoto O; Imai-Okazaki A; Yamazaki S; Seguchi O; Konno T; Hayashi K; Kawashiri MA; Asano Y; Kitakaze M; Takashima S; Yamagishi M
ESC Heart Fail; 2019 Apr; 6(2):406-415. PubMed ID: 30690923
[TBL] [Abstract][Full Text] [Related]
31. The functional effect of dilated cardiomyopathy mutation (R144W) in mouse cardiac troponin T is differently affected by α- and β-myosin heavy chain isoforms.
Gollapudi SK; Tardiff JC; Chandra M
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H884-93. PubMed ID: 25681424
[TBL] [Abstract][Full Text] [Related]
32. Predominant myosin superrelaxed state in canine myocardium with naturally occurring dilated cardiomyopathy.
Ochala J; Lewis CTA; Beck T; Iwamoto H; Hessel AL; Campbell KS; Pyle WG
Am J Physiol Heart Circ Physiol; 2023 Sep; 325(3):H585-H591. PubMed ID: 37505469
[TBL] [Abstract][Full Text] [Related]
33. Manipulating myosin light chain 2 isoforms in vivo: a transgenic approach to understanding contractile protein diversity.
Kelly R; Buckingham M
Circ Res; 1997 May; 80(5):751-3. PubMed ID: 9130457
[No Abstract] [Full Text] [Related]
34. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.
Infante M; Ricordi C; Fabbri A
J Diabetes; 2020 Sep; 12(9):659-667. PubMed ID: 32401405
[TBL] [Abstract][Full Text] [Related]
35. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
[TBL] [Abstract][Full Text] [Related]
36. Early sensitization of myofilaments to Ca2+ prevents genetically linked dilated cardiomyopathy in mice.
Alves ML; Warren CM; Simon JN; Gaffin RD; Montminy EM; Wieczorek DF; Solaro RJ; Wolska BM
Cardiovasc Res; 2017 Jul; 113(8):915-925. PubMed ID: 28379313
[TBL] [Abstract][Full Text] [Related]
37. Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.
Lynch TL; Ismahil MA; Jegga AG; Zilliox MJ; Troidl C; Prabhu SD; Sadayappan S
J Mol Cell Cardiol; 2017 Jan; 102():83-93. PubMed ID: 27955979
[TBL] [Abstract][Full Text] [Related]
38. Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Attributable to a Human Myosin Regulatory Light Chain Mutation.
Zaleta-Rivera K; Dainis A; Ribeiro AJS; Cordero P; Rubio G; Shang C; Liu J; Finsterbach T; Parikh VN; Sutton S; Seo K; Sinha N; Jain N; Huang Y; Hajjar RJ; Kay MA; Szczesna-Cordary D; Pruitt BL; Wheeler MT; Ashley EA
Circulation; 2019 Aug; 140(9):765-778. PubMed ID: 31315475
[TBL] [Abstract][Full Text] [Related]
39. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
[TBL] [Abstract][Full Text] [Related]
40. Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.
Vikhorev PG; Vikhoreva NN; Yeung W; Li A; Lal S; Dos Remedios CG; Blair CA; Guglin M; Campbell KS; Yacoub MH; de Tombe P; Marston SB
Cardiovasc Res; 2022 Jan; 118(1):241-253. PubMed ID: 33135063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
